Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

16.76
-2.0900-11.09%
Post-market: 16.800.0400+0.24%19:54 EDT
Volume:3.01M
Turnover:52.23M
Market Cap:2.31B
PE:-14.74
High:19.33
Open:19.05
Low:16.67
Close:18.85
Loading ...
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 05, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 02, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2023

Major Issues Report

8-K - Current report
Apr 18, 2023

Correspondence

Form CORRESP - Correspondence
Mar 22, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 03, 2023

Correspondence

Form CORRESP - Correspondence
Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]